论文部分内容阅读
目的:观察化浊行血汤联合常规药物治疗短暂性脑缺血发作(TIA)的临床疗效。方法:选取70例血浊证TIA患者为研究对象,随机分为观察组与对照组各35例。对照组给予常规药物治疗,观察组在对照组用药基础上联合化浊行血汤治疗。治疗后比较2组临床疗效,观察2组治疗前后的超敏C-反应蛋白(hs-CRP)含量和血液流变学指标的变化。结果:观察组总有效率为91.43%,高于对照组的71.43%,差异有统计学意义(P<0.05)。治疗前,2组hs-CRP含量比较,差异无统计学意义(P>0.05)。治疗后,2组hs-CRP含量均较治疗前降低(P<0.05);组间hs-CRP含量比较,差异无统计学意义(P>0.05)。治疗前,2组全血黏度(高切)、全血黏度(低切)、血浆黏度和纤维蛋白原水平比较,差异均无统计学意义(P>0.05)。治疗后,2组4项血液流变学指标水平均较治疗前降低(P<0.05);观察组的4项血液流变学指标水平均低于对照组(P<0.05)。结论:化浊行血汤联合常规药物治疗血浊证TIA临床疗效显著,可有效降低患者的hs-CRP含量,改善患者的血液流变学指标,有推广应用于临床的价值。
Objective: To observe the clinical efficacy of Huzhuo xuexue decoction combined with conventional medicine in treating transient ischemic attack (TIA). Methods: TIA patients of 70 cases of blood turbid syndrome were selected and randomly divided into observation group and control group with 35 cases each. Control group given conventional drug treatment, the observation group in the control group based on the combination of Huazhuo blood soup treatment. After treatment, the clinical efficacy was compared between the two groups. The changes of hs-CRP and hemorheology indexes in two groups before and after treatment were observed. Results: The total effective rate in observation group was 91.43%, which was higher than that in control group (71.43%), the difference was statistically significant (P <0.05). Before treatment, there was no significant difference in hs-CRP levels between the two groups (P> 0.05). After treatment, the content of hs-CRP in both groups was lower than that before treatment (P <0.05). There was no significant difference in hs-CRP levels between the two groups (P> 0.05). Before treatment, there was no significant difference between the two groups in whole blood viscosity (high shear), whole blood viscosity (low shear), plasma viscosity and fibrinogen level (P> 0.05). After treatment, the levels of 4 hemorheological indexes in 2 groups were lower than those before treatment (P <0.05). The 4 indexes of hemorheology in observation group were lower than those in control group (P <0.05). Conclusion: The clinical efficacy of Huazhuo Xuexue decoction combined with conventional medicine in treating blood turbidity syndrome is significant, which can effectively reduce the content of hs-CRP in patients and improve the hemorrheological indexes of patients. It has the value of clinical application.